Literature DB >> 32504657

Laser Interstitial Thermal Therapy in the treatment of brain metastases and radiation necrosis.

Dhiego Chaves de Almeida Bastos1, Jeffrey Weinberg2, Vinodh A Kumar3, David T Fuentes4, Jason Stafford5, Jing Li6, Ganesh Rao7, Sujit S Prabhu8.   

Abstract

Stereotactic Radiosurgery has become the main treatment for patients with limited number of brain metastases (BM). Recently, with the increasing use of this modality, there is a growth in recurrence cases. Recurrence after radiation therapy can be divided in changes favoring either tumor recurrence or radiation necrosis (RN). Laser Interstitial Thermal Therapy (LITT) is minimally invasive treatment modality that has been used to treat primary and metastatic brain tumors. When associated with real-time thermometry using Magnetic Resonance Imaging, the extent of ablation can be controlled to provide maximum coverage and avoid eloquent areas. The objective of this study was to investigate the use of LITT in the treatment of BM. An extensive review of the relevant literature was conducted and the outcome results are discussed. There is an emphasis on safety and local control rate of patients treated with this modality. The findings of our study suggest that LITT is a viable safe technique to treat recurrent BM, especially in patients with deep-seated lesions where surgical resection is not an option.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brain metastases; Brain tumors; Laser Interstitial Thermal Therapy; Radiation necrosis; Thermometry

Year:  2020        PMID: 32504657     DOI: 10.1016/j.canlet.2020.05.014

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

Review 1.  DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment.

Authors:  Denise Bernhardt; Laila König; Anca-L Grosu; Stefan Rieken; Sandro M Krieg; Wolfgang Wick; Benedikt Wiestler; Friederike Schmidt-Graf; Felix Sahm; Jens Gempt; Bernhard Meyer; Bernd J Krause; Cordula Petersen; Rainer Fietkau; Michael Thomas; Frank Giordano; Andrea Wittig-Sauerwein; Jürgen Debus; Ghazaleh Tabatabai; Peter Hau; Joachim Steinbach; Stephanie E Combs
Journal:  Strahlenther Onkol       Date:  2022-08-29       Impact factor: 4.033

Review 2.  Review of Current Principles of the Diagnosis and Management of Brain Metastases.

Authors:  Alex W Brenner; Akash J Patel
Journal:  Front Oncol       Date:  2022-05-24       Impact factor: 5.738

Review 3.  Clinical strategies to manage adult glioblastoma patients without MGMT hypermethylation.

Authors:  Delin Liu; Tianrui Yang; Wenbin Ma; Yu Wang
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

4.  Preservation of neurocognitive function in the treatment of brain metastases.

Authors:  Michael W Parsons; Katherine B Peters; Scott R Floyd; Paul Brown; Jeffrey S Wefel
Journal:  Neurooncol Adv       Date:  2021-11-27

Review 5.  Surgical Management of Brain Metastasis: Challenges and Nuances.

Authors:  Chibawanye I Ene; Sherise D Ferguson
Journal:  Front Oncol       Date:  2022-03-14       Impact factor: 6.244

Review 6.  Quality of Life and Cognitive Function Evaluations and Interventions for Patients with Brain Metastases in the Radiation Oncology Clinic.

Authors:  Jennifer K Matsui; Haley K Perlow; Cyril Baiyee; Alex R Ritter; Mark V Mishra; Joseph A Bovi; Vinai Gondi; Paul D Brown; Ashlee R Loughan; Heather E Leeper; Erica Dawson; Joshua D Palmer
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

7.  Bevacizumab vs laser interstitial thermal therapy in cerebral radiation necrosis from brain metastases: a systematic review and meta-analysis.

Authors:  Paolo Palmisciano; Ali S Haider; Chibueze D Nwagwu; Waseem Wahood; Salah G Aoun; Kalil G Abdullah; Tarek Y El Ahmadieh
Journal:  J Neurooncol       Date:  2021-07-03       Impact factor: 4.130

Review 8.  Laser Interstitial Thermal Therapy for Posterior Fossa Lesions: A Systematic Review and Analysis of Multi-Institutional Outcomes.

Authors:  Mohammadmahdi Sabahi; Stephen J Bordes; Edinson Najera; Alireza M Mohammadi; Gene H Barnett; Badih Adada; Hamid Borghei-Razavi
Journal:  Cancers (Basel)       Date:  2022-01-17       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.